Exhibit 99.1 ------------ JOINT FILING AGREEMENT PURSUANT TO RULE 13d-1(k)(1) ---------------------------- The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all...Joint Filing Agreement • February 9th, 2005 • Feinberg Larry N • Pharmaceutical preparations
The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that it knows or has reason to believe that such information is inaccurate. This Agreement may be executed in any number of counterparts and all of such counterparts taken together shall constitute one and the same instrument.
Exhibit 99.1 Joint Filing Agreement The undersigned hereby agree that this Amendment No. 2 to Schedule 13G (as so amended, the "Schedule 13G") with respect to the common stock of Transition Therapeutics Inc. is, and any additional amendment thereto...Joint Filing Agreement • May 20th, 2009 • Feinberg Larry N • Medicinal chemicals & botanical products
The undersigned hereby agree that this Amendment No. 2 to Schedule 13G (as so amended, the "Schedule 13G") with respect to the common stock of Transition Therapeutics Inc. is, and any additional amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to the Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that it knows or has reason to believe that such information is inaccurate.
Exhibit 99.2 ------------ Joint Filing Agreement The undersigned hereby agree that this statement on Schedule 13D with respect to the securities of Mediware Information Systems, Inc. is, and any amendment thereto signed by each of the undersigned...Exhibit 99 • February 11th, 2005 • Feinberg Larry N • Services-computer integrated systems design
The undersigned hereby agree that this statement on Schedule 13D with respect to the securities of Mediware Information Systems, Inc. is, and any amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended and that all subsequent amendments to this statement on Schedule 13D shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that it knows or has reason to believe that such information is inaccurate.
Form of Warrant THIS WARRANT AND THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, AND MAY NOT BE OFFERED, SOLD, ASSIGNED OR TRANSFERRED, IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT...Feinberg Larry N • May 22nd, 2008 • Pharmaceutical preparations • New York
Manner of Exercise. From and after the Closing Date, and until 5:00 P.M., New York time, on the Expiration Date (the “Exercise Period”), the Holder may exercise this Warrant, on any Business Day, for all or any part of the number of shares of Warrant Stock purchasable hereunder. The exercise price per share of the Common Stock under this Warrant shall be the Current Warrant Price, subject to adjustment hereunder.
Exhibit 1 --------- Joint Filing Agreement The undersigned hereby agree that the statement on Schedule 13D with respect to the common stock of Halsey Drug Co., Inc. is, and any amendment thereto signed by each of the undersigned shall be, filed on...Joint Filing Agreement • August 10th, 2001 • Feinberg Larry N • Textile mill products
The undersigned hereby agree that the statement on Schedule 13D with respect to the common stock of Halsey Drug Co., Inc. is, and any amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended.
ContractFeinberg Larry N • March 12th, 2015 • Orthopedic, prosthetic & surgical appliances & supplies • Delaware
NEITHER THIS WARRANT, NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT (COLLECTIVELY, THE “SECURITIES”), HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER ANY STATE SECURITIES OR BLUE SKY LAWS. THE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE OFFERED, SOLD, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED EXCEPT AS PERMITTED UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES OR BLUE SKY LAWS, PURSUANT TO REGISTRATION OR QUALIFICATION OR EXEMPTION THEREFROM. INVESTORS SHOULD BE AWARE THAT THEY MAY BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME. THE ISSUER OF THE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY PROPOSED TRANSFER IS IN COMPLIANCE WITH THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES OR BLUE SKY LAWS.
EXHIBIT 1 SCHEDULE 13D JOINT FILING AGREEMENT The undersigned and each other person executing this joint filing agreement (this "Agreement") agree that each of the undersigned is responsible for the timely filing of this statement and any amendments...Joint Filing Agreement • September 25th, 2002 • Feinberg Larry N • Electromedical & electrotherapeutic apparatus
The undersigned and each other person executing this joint filing agreement (this "Agreement") agree that each of the undersigned is responsible for the timely filing of this statement and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained herein or therein; but none of the undersigned is responsible for the completeness or accuracy of the information statement concerning any other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 23rd, 2014 • Feinberg Larry N • Dental equipment & supplies • Delaware
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) dated July 18, 2014, is entered into by and among (i) Biolase, Inc., a Delaware corporation (the “Company”), and (ii) each person listed on Schedule I hereto (each, an “Investor” and, collectively, the “Investors”).
SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • March 12th, 2015 • Feinberg Larry N • Orthopedic, prosthetic & surgical appliances & supplies • Delaware
This SECOND AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT (the “Agreement”) is made as of March 11, 2015 by and among Hansen Medical, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), Oracle Partners, LP, Oracle Institutional Partners, LP and Oracle Ten Fund Master, LP (together, “Oracle”), Schuler Family Foundation (the “Schuler Family Foundation” and together with Oracle, the “Principal Purchasers”) and the other parties whose names appear on the signature pages hereto (collectively with the Principal Purchasers and those existing investors whose names appear on Schedule I hereto, the “Purchasers”).
SUBSCRIPTION AGREEMENTSubscription Agreement • February 13th, 2014 • Feinberg Larry N • Dental equipment & supplies • Delaware
The undersigned understand that Biolase, Inc., a corporation organized under the laws of Delaware (the “Company”), is offering an aggregate of 1,945,525 shares of its common stock, par value $0.001 per share (“Common Stock” and such shares of Common Stock, the “Securities”), in a private placement. The undersigned further understand that the offering is being made without registration of the Securities under the Securities Act of 1933, as amended (the “Securities Act”), or any securities law of any state of the United States or of any other jurisdiction.
Preferred Stock and Warrant Purchase Agreement PREFERRED STOCK AND WARRANT PURCHASE AGREEMENT by and among Access Pharmaceuticals, Inc. and the parties named herein on Schedule 1, as Purchasers November 7, 2007Preferred Stock and Warrant Purchase Agreement • May 22nd, 2008 • Feinberg Larry N • Pharmaceutical preparations • New York
SCHEDULE 13G JOINT FILING AGREEMENT13g Joint Filing Agreement • February 13th, 2015 • Feinberg Larry N • Pharmaceutical preparations
The undersigned hereby agree that this Schedule 13G (as so amended, the “Schedule 13G”) with respect to the common stock, par value $0.01 per share, of PlasmaTech Biopharmaceuticals, Inc. is, and any additional amendment thereto signed by each of the undersigned shall be, filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to the Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that it knows or has reason to believe that such information is inaccur
JOINT FILING AGREEMENTJoint Filing Agreement • June 6th, 2013 • Feinberg Larry N • Surgical & medical instruments & apparatus
THIS JOINT FILING AGREEMENT is entered into as of June 6, 2013, by and among the parties signatories hereto. The undersigned hereby agree that the Statement on Schedule 13D with respect to the beneficial interests in the American Depositary Shares represented by American Depositary Receipts (each representing two Ordinary Shares, par value $NIS 0.01 per share), of Mazor Robotics Ltd., an Israeli company, is, and any amendment thereafter signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
SCHEDULE 13G JOINT FILING AGREEMENTSchedule 13g Joint Filing Agreement • December 30th, 2013 • Feinberg Larry N • Electromedical & electrotherapeutic apparatus
The undersigned hereby agree that this Schedule 13G (as so amended, the “Schedule 13G”) with respect to the common stock of NxStage Medical, Inc. is, and any additional amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to the Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that it knows or has reason to believe that such information is inaccurate.
JOINT FILING AGREEMENTJoint Filing Agreement • May 23rd, 2013 • Feinberg Larry N • In vitro & in vivo diagnostic substances
THIS JOINT FILING Agreement is entered into as of May 23, 2013, by and among the parties signatories hereto. The undersigned hereby agree that the Statement on Schedule 13D with respect to the shares of the common stock, par value $0.001 per share, of Vermillion, Inc., a Delaware corporation, is, and any amendment thereafter signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
SCHEDULE 13G JOINT FILING AGREEMENTSchedule 13g Joint Filing Agreement • April 18th, 2013 • Feinberg Larry N • Services-home health care services
The undersigned hereby agree that this Schedule 13G (as so amended, the “Schedule 13G”) with respect to the common stock of Gentiva Health Services, Inc. is, and any additional amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to the Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that it knows or has reason to believe that such information is inaccurate.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 7th, 2014 • Feinberg Larry N • Dental equipment & supplies • Delaware
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) dated November 3, 2014, is entered into by and among (i) Biolase, Inc., a Delaware corporation (the “Company”), and (ii) each person listed on Schedule I (each, an “Investor” and, collectively, the “Investors”).
JOINT FILING AGREEMENTJoint Filing Agreement • October 30th, 2015 • Feinberg Larry N • Surgical & medical instruments & apparatus
THIS JOINT FILING AGREEMENT is entered into as of October 30, 2015, by and among the parties signatories hereto. The undersigned hereby agree that the Statement on Schedule 13D with respect to the beneficial interests in the American Depositary Shares represented by American Depositary Receipts (each representing two Ordinary Shares, par value $NIS 0.01 per share) of Mazor Robotics Ltd., an Israeli company, is, and any amendment thereafter signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
Exhibit 6 FORM OF OPTION AGREEMENT HALSEY DRUG CO., INC. NON-QUALIFIED STOCK OPTION AGREEMENT HALSEY DRUG CO., INC., a New York corporation (the "Company"), hereby grants Oracle Strategic Partners (the "Optionee"), an Option to purchase ___________...Form of Option Agreement • March 10th, 2003 • Feinberg Larry N • Pharmaceutical preparations • New York
SCHEDULE 13G JOINT FILING AGREEMENTSchedule 13g Joint Filing Agreement • March 21st, 2018 • Feinberg Larry N • Pharmaceutical preparations
The undersigned hereby agree that this Schedule 13G (as so amended, the “Schedule 13G”) with respect to the common stock of ContraFect Corporation is, and any additional amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to the Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that it knows or has reason to believe that such information is inaccurate.
JOINT FILING AGREEMENTJoint Filing Agreement • August 8th, 2013 • Feinberg Larry N • Orthopedic, prosthetic & surgical appliances & supplies
THIS JOINT FILING Agreement is entered into as of August 8, 2013, by and among the parties signatories hereto. The undersigned hereby agree that the Statement on Schedule 13D with respect to the shares of the common stock, par value $0.0001 per share, of Hansen Medical, Inc., a Delaware corporation, is, and any amendment thereafter signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
AMENDED JOINT FILING AGREEMENTJoint Filing Agreement • December 24th, 2014 • Feinberg Larry N • In vitro & in vivo diagnostic substances
In accordance with Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them of a statement on Schedule 13D (including amendments thereto) with respect to the Common Stock of the Company and further agree that this Amended Joint Filing Agreement be included as an Exhibit to such joint filings.
SCHEDULE 13G JOINT FILING AGREEMENT13g Joint Filing Agreement • December 26th, 2017 • Feinberg Larry N • Electromedical & electrotherapeutic apparatus
The undersigned hereby agree that this Schedule 13G (as may be amended from time to time, the “Schedule 13G”) with respect to the common stock, par value $0.001 per share, of Soleno Therapeutics, Inc. is, and any amendment thereto signed by each of the undersigned shall be, filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all amendments to the Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that it knows or has reason to believe that such information is inaccurate.
ContractFeinberg Larry N • December 24th, 2014 • In vitro & in vivo diagnostic substances • Delaware
NEITHER THIS WARRANT, NOR THE SECURITIES ISSUABLE UPON EXERCISE OF THIS WARRANT (COLLECTIVELY, THE “SECURITIES”), HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER ANY STATE SECURITIES OR BLUE SKY LAWS. THE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE OFFERED, SOLD, PLEDGED, HYPOTHECATED OR OTHERWISE TRANSFERRED EXCEPT AS PERMITTED UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES OR BLUE SKY LAWS, PURSUANT TO REGISTRATION OR QUALIFICATION OR EXEMPTION THEREFROM. INVESTORS SHOULD BE AWARE THAT THEY MAY BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME. THE ISSUER OF THE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL IN FORM AND SUBSTANCE REASONABLY SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY PROPOSED TRANSFER IS IN COMPLIANCE WITH THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES OR BLUE SKY LAWS.
JOINT FILING AGREEMENTJoint Filing Agreement • February 7th, 2012 • Feinberg Larry N • Pharmaceutical preparations
The undersigned hereby agree that this Schedule 13G (as so amended, the “Schedule 13G”) with respect to the common stock of GTx, Inc. is, and any additional amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to the Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that it knows or has reason to believe that such information is inaccurate.
SCHEDULE 13G JOINT FILING AGREEMENTSchedule 13g Joint Filing Agreement • February 9th, 2012 • Feinberg Larry N • Surgical & medical instruments & apparatus
The undersigned hereby agree that this Schedule 13G (as so amended, the “Schedule 13G”) with respect to the common stock of Accuray Incorporated is, and any additional amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to the Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that it knows or has reason to believe that such information is inaccurate.
JOINT FILING AGREEMENTJoint Filing Agreement • February 7th, 2012 • Feinberg Larry N • In vitro & in vivo diagnostic substances
The undersigned hereby agree that this Schedule 13G (as so amended, the “Schedule 13G”) with respect to the common stock of Quidel Corporation is, and any additional amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to the Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that it knows or has reason to believe that such information is inaccurate.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 12th, 2015 • Feinberg Larry N • Orthopedic, prosthetic & surgical appliances & supplies • Delaware
This Securities Purchase Agreement (this “Agreement”) is dated as of March 9, 2015, between Hansen Medical, Inc., a Delaware corporation (the “Company”), and each purchaser identified on Exhibit A hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SCHEDULE 13G JOINT FILING AGREEMENTSchedule 13g Joint Filing Agreement • August 29th, 2014 • Feinberg Larry N • Miscellaneous plastics products
The undersigned hereby agree that this Schedule 13G (as so amended, the “Schedule 13G”) with respect to the common stock of Metabolix, Inc. is, and any additional amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to the Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that it knows or has reason to believe that such information is inaccurate.
BIOLASE, INC.Securities Purchase Agreement • November 4th, 2019 • Feinberg Larry N • Dental equipment & supplies
Reference is made to that certain Securities Purchase Agreement (the “Purchase Agreement”), by and among BIOLASE, Inc. (the “Company” or “we”), the Schuler Family Foundation (the “Foundation”), and Oracle Partners, LP, Oracle Institutional Partners, LP and Oracle Ten Fund, LP (collectively with the Foundation, the “Investors”) pursuant to which the Investors purchased in the aggregate 69,565 shares of Series E Preferred Stock, par value $0.001 per share (“Series E Preferred Stock”), at a per share price of $57.50 in a private placement.
SCHEDULE 13G JOINT FILING AGREEMENTSchedule 13g Joint Filing Agreement • February 14th, 2020 • Feinberg Larry N • Surgical & medical instruments & apparatus
The undersigned hereby agree that this Schedule 13G (as so amended, the “Schedule 13G”) with respect to the common stock of Motus GI Holdings, Inc. is, and any additional amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to the Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that it knows or has reason to believe that such information is inaccurate.
JOINT FILING AGREEMENTJoint Filing Agreement • June 30th, 2015 • Feinberg Larry N • Surgical & medical instruments & apparatus
THIS JOINT FILING AGREEMENT is entered into as of June 30, 2015, by and among the parties signatories hereto. The undersigned hereby agree that the Statement on Schedule 13D with respect to the beneficial interests in the American Depositary Shares represented by American Depositary Receipts (each representing two Ordinary Shares, par value $NIS 0.01 per share) of Mazor Robotics Ltd., an Israeli company, is, and any amendment thereafter signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended.
ContractJoint Filing Agreement • May 22nd, 2008 • Feinberg Larry N • Pharmaceutical preparations
The undersigned hereby agree that this statement on Schedule 13D with respect to the securities of Access Pharmaceuticals, Inc. is, and any amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended and that all subsequent amendments to this statement on Schedule 13D shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that it knows or has reason to believe that such information is inaccurate.
SCHEDULE 13G JOINT FILING AGREEMENT13g Joint Filing Agreement • September 15th, 2016 • Feinberg Larry N • Laboratory analytical instruments
The undersigned hereby agree that this Schedule 13G (as may be amended from time to time, the “Schedule 13G”) with respect to the common stock, par value $0.001 per share, of Pacific Biosciences of California, Inc. is, and any amendment thereto signed by each of the undersigned shall be, filed on behalf of each of the undersigned pursuant to and in accordance with the provisions of Rule 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all amendments to the Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that it knows or has reason to believe that such information is in
SCHEDULE 13G JOINT FILING AGREEMENTSchedule 13g Joint Filing Agreement • February 12th, 2013 • Feinberg Larry N • Surgical & medical instruments & apparatus
The undersigned hereby agree that this Schedule 13G (as so amended, the “Schedule 13G”) with respect to the common stock of Accuray Incorporated is, and any additional amendment thereto signed by each of the undersigned shall be, filed on behalf of each undersigned pursuant to and in accordance with the provisions of 13d-1(k) under the Securities Exchange Act of 1934, as amended, and that all subsequent amendments to the Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning it contained therein, but shall not be responsible for the completeness and accuracy of the information concerning the other, except to the extent that it knows or has reason to believe that such information is inaccurate.
